IPG Photonics Corp IPGP
8 trading plans running, 17 Form 144 notices for $55.1M
10-Q, 10-K and Form 144What IPGP's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Mar 7, 2025 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Mary Buttarazzi Vice President, Corporate Controller and Chief Accounting Officer |
Adopted 10b5-1 plan | Sep 14, 2026 | 10-Q Nov 3, 2026 | ||
What the company wroteon September 14, 2026, Ms. Mary Buttarazzi, Vice President, Corporate Controller and Chief Accounting Officer of the Registrant, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 2,257 shares, including shares acquired upon vesting of restricted stock units. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until December 31, 2027, or earlier if all transactions under the trading arrangement are completed. | |||||
| Mr. Timothy P.V. Mammen Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | May 28, 2026 | 10-Q Aug 4, 2026 | ||
What the company wroteon May 28, 2026, Mr. Timothy P.V. Mammen, Senior Vice President and Chief Financial Officer of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 20,218 shares over a period beginning September 1, 2026 and ending May 10, 2027 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Mr. Eric Meurice Director |
Adopted 10b5-1 plan | May 7, 2026 | 10-Q Aug 4, 2026 | ||
What the company wroteon May 7, 2026, Mr. Eric Meurice, Director of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 5,321 shares, including shares acquired upon exercise of stock options, over a period beginning August 10, 2026 and ending August 9, 2027 on the open market at prevailing prices, subject to minimum price thresholds | |||||
| Dr. Eugene Scherbakov Director |
Adopted 10b5-1 plan | Mar 17, 2026 | 10-Q May 5, 2026 | ||
What the company wroteon March 17, 2026 Dr. Eugene Scherbakov, Director of the Registrant, and Mr. Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, adopted a joint Rule 10b5-1 trading arrangement with the following trusts: the Valentin Gapontsev Trust I, the Valentin Gapontsev Trust II, the Valentin Gapontsev Trust III (of which Dr. Scherbakov and Mr. Lopresti are trustees), and Share 1 GST Exempt Marital Share A under Article III of Valentin Gapontsev Trust I U/A DTD 08/01/2022, and a related company, IP Fibre Devices (UK) Limited. The arrangement allows for the sale of up to 15,240 shares by Dr. Scherbakov and up to 17,184 shares by Mr. Lopresti, over a period beginning June 17, 2026 and ending April 17, 2027 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Mr. Angelo P. Lopresti Senior Vice President, General Counsel and Corporate Secretary |
Adopted 10b5-1 plan | Mar 17, 2026 | 10-Q May 5, 2026 | ||
What the company wroteon March 17, 2026 Dr. Eugene Scherbakov, Director of the Registrant, and Mr. Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, adopted a joint Rule 10b5-1 trading arrangement with the following trusts: the Valentin Gapontsev Trust I, the Valentin Gapontsev Trust II, the Valentin Gapontsev Trust III (of which Dr. Scherbakov and Mr. Lopresti are trustees), and Share 1 GST Exempt Marital Share A under Article III of Valentin Gapontsev Trust I U/A DTD 08/01/2022, and a related company, IP Fibre Devices (UK) Limited. The arrangement allows for the sale of up to 15,240 shares by Dr. Scherbakov and up to 17,184 shares by Mr. Lopresti, over a period beginning June 17, 2026 and ending April 17, 2027 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Ms. Agnes Tang Director |
Adopted 10b5-1 plan | Aug 26, 2025 | 10-Q Nov 4, 2025 | ||
What the company wroteDuring the Registrant's last fiscal quarter ended September 30, 2025, the following director of the Registrant adopted a Rule 10b5-1 trading arrangement: • on August 26, 2025, Ms. Agnes Tang, Director of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 3,392 shares over a period beginning November 24, 2025 and ending November 24, 2026 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Dr. Eugene Scherbakov Director |
Adopted 10b5-1 plan | Jun 13, 2025 | 10-Q Aug 5, 2025 | ||
What the company wroteon June 13, 2025, Dr. Eugene Scherbakov, Director of the Registrant, and Mr. Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, adopted a joint Rule 10b5-1 trading arrangement with the following trusts (of which Dr. Scherbakov and Mr. Lopresti are trustees): the Valentin Gapontsev Trust I, the Valentin Gapontsev Trust II, the Valentin Gapontsev Trust III and a related company, IP Fibre Devices (UK) Limited. The arrangement allows for the sale of up to 16,000 shares by Dr. Scherbakov and up to 6,000 shares by Mr. Lopresti, over a period beginning September 15, 2025 and ending February 27, 2026 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Mr. Angelo P. Lopresti Senior Vice President |
Adopted 10b5-1 plan | Jun 13, 2025 | 10-Q Aug 5, 2025 | ||
What the company wroteon June 13, 2025, Dr. Eugene Scherbakov, Director of the Registrant, and Mr. Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, adopted a joint Rule 10b5-1 trading arrangement with the following trusts (of which Dr. Scherbakov and Mr. Lopresti are trustees): the Valentin Gapontsev Trust I, the Valentin Gapontsev Trust II, the Valentin Gapontsev Trust III and a related company, IP Fibre Devices (UK) Limited. The arrangement allows for the sale of up to 16,000 shares by Dr. Scherbakov and up to 6,000 shares by Mr. Lopresti, over a period beginning September 15, 2025 and ending February 27, 2026 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Mr. Trevor Ness Senior Vice President |
Adopted 10b5-1 plan | May 28, 2025 | 10-Q Aug 5, 2025 | ||
What the company wroteon May 28, 2025, Mr. Trevor Ness, Senior Vice President, Sales and Strategic Business Development of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 6,715 shares over a period beginning August 18, 2025 and ending February 17, 2026 on the open market at prevailing prices, subject to minimum price thresholds | |||||
| Angelo Lopresti Senior Vice President, General Counsel and Corporate Secretary of the Registrant |
Ended 10b5-1 plan | Mar 17, 2025 | 10-Q May 6, 2025 | ||
What the company wroteon March 17, 2025, Mr. Angelo Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, terminated the Rule 10b5-1 trading arrangement for the sale of up to 10,000 shares over a period beginning March 17, 2025 and ending December 1, 2025 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Eric Meurice Director |
Adopted 10b5-1 plan | Mar 7, 2025 | 10-Q May 6, 2025 | ||
What the company wroteon March 7, 2025, Mr. Eric Meurice, Director, adopted a Rule 10b5-1 trading arrangement for the sale of up to 3,002 shares, including shares acquired upon exercise of stock options, over a period beginning June 7, 2025 and ending June 1, 2026 on the open market at prevailing prices, subject to minimum price thresholds; and | |||||
| Mr. Angelo Lopresti Senior Vice President, General Counsel and Corporate Secretary |
Ended 10b5-1 plan | Dec 13, 2024 | 10-K Feb 20, 2025 | ||
| Eric Meurice Director |
Adopted 10b5-1 plan | May 3, 2024 | 10-Q Jul 30, 2024 | ||
What the company wroteon May 3, 2024, Mr. Eric Meurice, Director, adopted a Rule 10b5-1 trading arrangement for the sale of up to 2,255 shares, including shares acquired upon exercise of stock options, over a period beginning August 2, 2024 and ending June 1, 2025 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Angelo P. Lopresti Senior Vice President, General Counsel and Corporate Secretary |
Adopted 10b5-1 plan | Mar 12, 2024 | 10-Q Apr 30, 2024 | ||
What the company wroteon March 12, 2024, Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary, adopted a Rule 10b5-1 trading arrangement for the sale of up to 10,000 shares, over a period beginning June 13, 2024 and ending June 12, 2025 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Ms. Agnes Tang Director |
Adopted 10b5-1 plan | Jun 15, 2023 | 10-Q Aug 1, 2023 | ||
What the company wroteon June 15, 2023, Ms. Agnes Tang, Director, adopted a Rule 10b5-1 trading arrangement for the sale of up to 900 shares over a period beginning September 13, 2023 and ending March 31, 2024 on the open market at prevailing prices, subject to minimum price thresholds. | |||||
| Dr. Eugene Scherbakov Director and CEO |
Adopted 10b5-1 plan | May 10, 2023 | 10-Q Aug 1, 2023 | ||
What the company wroteon May 10, 2023, Dr. Eugene Scherbakov, Director and CEO, adopted a Rule 10b5-1 trading arrangement for the sale of up to 13,000 shares, including shares acquired upon exercise of stock options, over a period beginning August 13, 2023 and ending February 28, 2024 on the open market at prevailing prices, subject to minimum price thresholds | |||||
| Mr. Trevor Ness Senior Vice President, Chief Revenue Officer |
Adopted 10b5-1 plan | – | 10-Q May 5, 2026 | ||
What the company wroteon March 17, 2026, Mr. Trevor Ness, Senior Vice President, Chief Revenue Officer of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 12,212 shares, including shares acquired upon exercise of stock options, over a period beginning June 17, 2026 and ending June 16, 2027 on the open market at prevailing prices, subject to minimum price thresholds | |||||
| Paulus Bucher Senior Vice President, Global Operations |
Adopted 10b5-1 plan | – | 10-Q Nov 3, 2026 | ||
What the company wroteon August 27, 2026, Mr. Paulus Bucher, Senior Vice President, Global Operations of the Registrant, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 2,604 shares, including shares acquired upon vesting of restricted stock units. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until May 10, 2027, or earlier if all transactions under the trading arrangement are completed. | |||||
Show the other 10 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 17 filings checked since May 2, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Oct 2, 2026 | IP FIBRE DEVICES LTD 10% Stockholder |
135,000 | $11.6M |
| Oct 2, 2026 | SCHERBAKOV EUGENE A 10% Stockholder |
7,620 | $650K |
| Sep 22, 2026 | Valentin Gapontsev Trust II Officer |
11,688 | $909K |
| Jun 29, 2026 | Lopresti Angelo P Officer |
3,000 | $331K |
| Jun 29, 2026 | IP FIBRE DEVICES LTD 10% Stockholder |
197,100 | $20.4M |
| Jun 29, 2026 | SCHERBAKOV EUGENE A Director |
4,572 | $464K |
| Jun 22, 2026 | Valentin Gapontsev Trust II Officer |
12,876 | $1.5M |
| Jun 22, 2026 | Agnes Tang Director |
1,511 | $178K |
| May 22, 2026 | Mammen Timothy PV Officer |
9,975 | $1.2M |
| May 14, 2026 | Desmond Jeanmarie F. Director |
1,690 | $178K |
| Mar 17, 2026 | Buttarazzi Mary E. Officer |
500 | $58K |
| Feb 2, 2026 | Meurice Eric Director |
750 | $71K |
| Jan 21, 2026 | Lopresti Angelo P Officer |
1,500 | $128K |
| Dec 23, 2025 | SCHERBAKOV EUGENE A Officer |
8,100 | $603K |
| Dec 22, 2025 | IP FIBRE DEVICES LTD 10% Stockholder |
192,501 | $14.6M |
| Dec 19, 2025 | Valentin Gapontsev Trust II Officer |
27,945 | $2.1M |
| Nov 25, 2025 | Agnes Tang Director |
1,881 | $144K |
Show the other 9 notices
From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IPGP/export.csv") into a cell.